NEWS

Don\'t Miss Our Night of Beauty - February 7th

Join Matossian Eye Associates for a unique and exquisite evening to learn the latest aesthetic techn... | read full article

Holiday Hours 12/23/17 - 1/2/18

During the upcoming Holiday season, Matossian Eye Associates offices will have the following hours a... | read full article

Digital Scribes

Stanford Medicine recently has announced that it is working with Google Research on a “digital... | read full article

read more news stories

Xiidra™

The FDA recently approved Xiidra™ as a treatment for the signs and symptoms of dry eye disease. It is the first and only prescription eye drop approved for both the signs and symptoms of dry eye disease. This remarkable product is available by prescription only and is now available at all major pharmacies. Matossian Eye Associates was one of the premier clinical trial sites to offer valuable contributions and interest in this important milestone, playing an instrumental role in making this new treatment available for our patients. Owner, Founder, and Chief Medical officer of Matossian Eye Associates and Principal Investigator in the Xiidra™ clinical study Cynthia Matossian, MD, FACS said, “With the epidemic of Dry Eye Disease, we are fortunate to have an additional medicine like Xiidra™ to bring relief to the millions who suffer dry eye symptoms daily.”

Matossian Eye Associates is one of the few practices in the greater area to have samples of Xiidra™ for our patients to try. If you are experiencing stinging or burning eyes, a gritty or scratchy sensation, discomfort in contact lenses, blurred vision, light sensitivity, redness, excessive tearing, and a reliance on artificial tears to get through the day, please call us at 1(800) 708-8800 to schedule a dry eye consult by a fellowship trained, board certified physicians in our Certified Dry Eye Center of Excellence! Please click the video below to hear actress Jennifer Aniston’s experience with dry eye.

 

#EYEPOWERMENT